EN DE

The Klinique Medical Clinic Public Company (KLINIQ) Fair Value & Analysis

Consumer Cyclical · TH · Market cap 6.0B THB

TK The Klinique Medical Clinic Public Company KLINIQ · BK
Price29.00 THB
Fair Value33.82 THB
Upside+16.6%
Quality70/100
Watch The Klinique Medical Clinic Public Company for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Solidly profitable · 10.5% net margin
generates free cash flow
5.42% dividend yield
Ranks above peers (12/14)
Moderate moat 63/100
Evidence: High Range 24.33 THB – 43.30 THB Share as image

Fair value as of: Jul 14, 2026

From 26 valuation models · updated 27 days ago

Share price +8.4% over the past month.

A solid business, screening 17% undervalued on our models.

What matters now

  • Our model range runs from 24.33 THB (bear) to 43.30 THB (bull), base 33.82 THB. The closer the price sits to the lower half, the larger the margin of safety.
  • Quality 70/100 (solid quality) with high evidence: the data supports the verdict.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (4 years)

40.59 THB 19.24 THB Fair Value 33.82 THB Nov 2022 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 14, 2026.

How to read this chart

45‑month range 19.24 THB – 40.59 THB · fair‑value band 24.33 THB – 43.30 THB · the 29.00 THB price screens below the 33.82 THB fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 14, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

The Klinique Medical Clinic Public Company (KLINIQ) currently trades at 29.00 THB, while our model-based Fair Value estimate is 33.82 THB, implying the stock looks roughly 16.6% undervalued today. The Quality Score stands at 70/100 (solid quality), in the Consumer Cyclical sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, The Klinique Medical Clinic Public Company generated revenue of 3.8B THB at a net margin of 10.5%. Revenue grew 33.5% year over year. It earns a return on equity of 21.5%. Net debt stands at 909M THB. Fundamentals as of Jul 14, 2026

Our scenario range runs from 24.33 THB (bear case) to 43.30 THB (bull case); at 29.00 THB, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 3% below its 52-week high and 52% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at -16% fair-value upside, at 17%, KLINIQ screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Residual Income 9.97 THB 12.05 THB 28.09 THB 76
Growth DCF 26.64 THB 46.76 THB 86.12 THB 72
Gordon GGM 12.73 THB 25.37 THB 38.42 THB 70
All 26 models by family
DCF Models
FCF DCF 28.28 THB 42.77 THB 87.94 THB 38
Owner Earnings 27.83 THB 59.94 THB 124.86 THB 31
5Y Revenue Exit 19.85 THB 32.18 THB 57.91 THB 39
5Y EBITDA Exit 33.01 THB 58.79 THB 109.40 THB 41
5Y P/E Exit 29.25 THB 63.65 THB 110.55 THB 38
10Y Revenue Exit 22.08 THB 44.04 THB 57.18 THB 36
10Y EBITDA Exit 32.06 THB 71.73 THB 141.59 THB 37
10Y P/E Exit 29.37 THB 63.81 THB 120.43 THB 35
Earnings-Based
Graham-Dodd 11.24 THB 78.40 THB 110.02 THB 54
Lynch FV 29.89 THB 42.70 THB 55.51 THB 50
PEG = 1.0 29.89 THB 42.70 THB 55.51 THB 46
EPV 16.59 THB 18.98 THB 21.04 THB 59
Dividend Discount
Gordon GGM 12.73 THB 25.37 THB 38.42 THB 70
DDM Multi-Stage 12.73 THB 21.93 THB 26.79 THB 61
Multiples
P/E Multiple 27.28 THB 36.37 THB 45.46 THB 63
P/S Multiple 14.55 THB 19.40 THB 24.25 THB 58
P/B Multiple 21.08 THB 28.10 THB 35.13 THB 55
EV/EBIT 29.89 THB 39.38 THB 48.86 THB 53
EV/EBITDA 33.80 THB 44.60 THB 55.39 THB 54
EV/Revenue 15.01 THB 20.83 THB 26.65 THB 43
Asset-Based
NCAV (Graham) 4.03 THB 5.40 THB 8.06 THB 50
Growth DCF
Growth DCF 26.64 THB 46.76 THB 86.12 THB 72
Rev-Margin DCF 20.02 THB 36.62 THB 67.94 THB 67
Economic Profit
Residual Income 9.97 THB 12.05 THB 28.09 THB 76
ROIC Compounder 21.08 THB 30.52 THB 40.91 THB 67
Growth Earnings
Growth-Adj P/E 38.76 THB 55.37 THB 71.98 THB 68

Widest divergence: DCF Models (58.79 THB) versus Asset-Based (5.40 THB). Highest evidence: Residual Income (76).

Notify me when KLINIQ reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 3.8B THB
Revenue growth (YoY) +33.5%
Net margin 10.5%
Return on equity 21.5%
Free cash flow 371M THB FY2025
P/E ratio 14.4
More key figures
Operating margin 14.8%
EPS (TTM) 1.81 THB
Dividend yield 5.5%
EPS growth (YoY) +42.8%
Net debt 909M THB FY2025

Figures from reported company fundamentals · as of Jul 14, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 70/100

Of which business quality 70 · Market factors (momentum, volatility) 74

Profitability 71
Margins and returns on capital today
Quality Growth 59
Are margins and returns improving?
Cashflow 61
Earnings quality: real cash, not paper profit
Fin. Strength 81
Balance sheet, leverage, solvency risk
Investment 67
Disciplined investing over empire-building
Low Volatility 76
Calm price path (market factor)
Momentum 68
Price trend over the last 3–12 months (market factor)
52W Momentum 81
Distance to the 52-week high (market factor)
Net Issuance 82
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

The Klinique Medical Clinic Public Company Limited provides skin medical treatment services under the Klinique brand name in Thailand.

Full company description

The Klinique Medical Clinic Public Company Limited provides skin medical treatment services under the Klinique brand name in Thailand. Its services include face lift, acne, pimples, and acne scars, skin tightening, filler, fat dissolving injection, laser hair removal, skin treatment, skin injection, mesofront, mesotherapy, and rhinoplasty, as well as nose, eye, and facial surgery. The company also offers skin medical services and distribution of cosmetics and medical cosmetics, and surgery services. The Klinique Medical Clinic Public Company Limited was founded in 2009 and is based in Bangkok, Thailand.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

The Klinique Medical Clinic Public Company reported revenue of 3.6B THB in FY2025 versus 950M THB in FY2021, a compound +39.1%/yr. Reported net income was 364M THB in FY2025, compounding +29.5%/yr from FY2021.

Growth Quality 92/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
3.6B THB
Latest YoY
+19.2%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+29.5%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+28.9%
Avg. growth/yr (12Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+26.2%
Revenue +39.1%/yr
FY21 950M THB
FY22 1.6B THB
FY23 2.3B THB
FY24 3.0B THB
FY25 3.6B THB
Net income +29.5%/yr
FY21 129M THB
FY22 205M THB
FY23 289M THB
FY24 322M THB
FY25 364M THB
Character of growth · EPS growth decomposed (2015-2025) +7.8 % p.a.
Revenue per share +2.9 pp

of which total revenue +19.4 pp · buybacks/dilution −16.5 pp

EBIT margin +4.8 pp
Tax rate −0.1 pp
Residual (interest, one-offs) +0.2 pp

Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).

Watch KLINIQ: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "The Klinique Medical Clinic Public Company Fair Value". https://www.fairvalue-calculator.com/stock/KLINIQ

Peer Group

Personal Services · 42 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 70 · Top 25%
Fair Value upside +17% · Above median
Return on equity (TTM) 22% · Above median
Return on assets 10% · Top 25%
Net margin (TTM) 10% · Above median
Operating margin (TTM) 15% · Above median
Revenue growth 34% · Top 25%
Dividend yield (TTM) 5.4% · Top 25%

Valuation Multiples vs Personal Services median · lower = cheaper

P/E (TTM) 15.2× · Cheaper than median
P/B 3.41× · Pricier than 75% of peers
P/S (TTM) 1.58× · Pricier than median
P/FCF 0.5× · Cheaper than 75% of peers
EV/EBITDA 8.4× · Cheaper than median
PEG 1.17× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 55 · sector 13
FUTURE 100 · sector 23
PAST 86 · sector 28
HEALTH 0 · sector 94
DIVIDEND 100 · sector 74

Insider activity: 30/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Personal Services stocks, each showing price versus our Fair Value estimate (as of Jul 14, 2026).

Stock Price Fair Value vs Fair Value
Rollins, Inc ROL $44.47 $21.11 -53%
Service Corporation SCI $78.72 $39.27 -50%
Frontdoor, Inc FTDR $75.69 $75.55 -0%
H&R Block, Inc HRB $41.14 $78.83 +92%
Bright Horizons Family Solutions Inc BFAM $73.99 $62.41 -16%
Fu Shou Yuan International Group 1448 HK$2.64 HK$4.20 +59%
Lungyen Life Service Corporation 5530 48.60 TWD 31.33 TWD -36%
Carriage Services, Inc CSV $38.29 $26.63 -30%
Musti Group MUSTI €14.35 €14.08 -2%
Uniao Pet Participacoes S.A AUAU3 R$3.08 R$1.37 -56%

Compare The Klinique Medical Clinic Public Company with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is The Klinique Medical Clinic Public Company (KLINIQ) overvalued or undervalued?
As of Jul 14, 2026, our model estimates a fair value of 33.82 THB versus a price of 29.00 THB, about +17% (undervalued).
What is the fair value of KLINIQ?
Our model-based fair value for The Klinique Medical Clinic Public Company is 33.82 THB (as of Jul 14, 2026), built from audited fundamentals. The current price is 29.00 THB.
What is the quality score of KLINIQ?
The Klinique Medical Clinic Public Company has a Quality Score of 70/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of The Klinique Medical Clinic Public Company (KLINIQ)?
The Klinique Medical Clinic Public Company reported trailing-twelve-month revenue of about 3.8B THB (latest available figure, as of Jul 14, 2026).
What is the net profit margin of KLINIQ?
The net profit margin of The Klinique Medical Clinic Public Company is about 10.5%, meaning it keeps roughly 10.5% of revenue as net income. Based on the latest reported figures.
Does The Klinique Medical Clinic Public Company pay a dividend?
The Klinique Medical Clinic Public Company currently shows a dividend yield of about 5.52% relative to its recent price (as of Jul 14, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track The Klinique Medical Clinic Public Company and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.